Julie C Michael1, Nermeen E El Nokali2, Jessica J Black3, Dana L Rofey4. 1. Divisions of Endocrinology and Behavioral Health, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania. Electronic address: juliecmichael@gmail.com. 2. Division of Weight Management, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania. 3. Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania. 4. Division of Weight Management, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
STUDY OBJECTIVE: To provide initial insight into physical activity patterns and predictors of moderate to vigorous physical activity (MVPA) in youth with polycystic ovary syndrome (PCOS) by using a multisensor activity monitor. DESIGN: Cross-sectional study analyzing baseline MVPA data using real-time continuous monitoring of physical activity. Body mass index (BMI) and depressive symptoms were examined as predictors of MVPA. SETTING: A large, urban children's hospital in the United States. PARTICIPANTS: Thirty-five youth (aged 12 to 21 years) previously diagnosed with PCOS (mean BMI = 38.0 kg/m(2); mean age = 15.4 years, 79% white) who were participants in a behavioral lifestyle intervention. MAIN OUTCOME MEASURES: Total steps, total MVPA, longest continuous bout of MVPA, and frequency of MVPA bouts lasting for 5 to 9 minutes and 10 or more minutes. RESULTS: Sixty percent of youth averaged at least 1 daily MVPA bout lasting 10 or more minutes, and 14% averaged a daily MVPA bout lasting 30 or more minutes. BMI was negatively correlated with MVPA bout duration (P = .04). Parental ratings of depression, but not self-report ratings, were predictive of participants' total MVPA (β = -.46; P = .01), number of 5- to 9-minute bouts (β = -.39; P = .03), and bouts of 10 or more minutes (β = -.35; P = .05). CONCLUSION: Youth with PCOS may benefit from being prescribed multiple bouts of MVPA lasting less than 30 continuous minutes to meet national recommendations and achieve health benefits. BMI and parental endorsement of child's depression symptoms may be important to consider when assessing and prescribing MVPA to youth with PCOS.
STUDY OBJECTIVE: To provide initial insight into physical activity patterns and predictors of moderate to vigorous physical activity (MVPA) in youth with polycystic ovary syndrome (PCOS) by using a multisensor activity monitor. DESIGN: Cross-sectional study analyzing baseline MVPA data using real-time continuous monitoring of physical activity. Body mass index (BMI) and depressive symptoms were examined as predictors of MVPA. SETTING: A large, urban children's hospital in the United States. PARTICIPANTS: Thirty-five youth (aged 12 to 21 years) previously diagnosed with PCOS (mean BMI = 38.0 kg/m(2); mean age = 15.4 years, 79% white) who were participants in a behavioral lifestyle intervention. MAIN OUTCOME MEASURES: Total steps, total MVPA, longest continuous bout of MVPA, and frequency of MVPA bouts lasting for 5 to 9 minutes and 10 or more minutes. RESULTS: Sixty percent of youth averaged at least 1 daily MVPA bout lasting 10 or more minutes, and 14% averaged a daily MVPA bout lasting 30 or more minutes. BMI was negatively correlated with MVPA bout duration (P = .04). Parental ratings of depression, but not self-report ratings, were predictive of participants' total MVPA (β = -.46; P = .01), number of 5- to 9-minute bouts (β = -.39; P = .03), and bouts of 10 or more minutes (β = -.35; P = .05). CONCLUSION: Youth with PCOS may benefit from being prescribed multiple bouts of MVPA lasting less than 30 continuous minutes to meet national recommendations and achieve health benefits. BMI and parental endorsement of child's depression symptoms may be important to consider when assessing and prescribing MVPA to youth with PCOS.
Authors: Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Vital Health Stat 11 Date: 2002-05
Authors: Natalie L Rasgon; Rekha C Rao; Sun Hwang; Lori L Altshuler; Shana Elman; Joni Zuckerbrow-Miller; Stanley G Korenman Journal: J Affect Disord Date: 2003-05 Impact factor: 4.839
Authors: Brooke Rossi; Sara Sukalich; Jennifer Droz; Adam Griffin; Stephen Cook; Aaron Blumkin; David S Guzick; Kathleen M Hoeger Journal: J Clin Endocrinol Metab Date: 2008-09-23 Impact factor: 5.958
Authors: Charles J Glueck; John A Morrison; Lisa Aronson Friedman; Naila Goldenberg; Davis M Stroop; Ping Wang Journal: Metabolism Date: 2006-04 Impact factor: 8.694
Authors: Karen P Jakubowski; Jessica J Black; Nermeen E El Nokali; Katherine A Belendiuk; Tamara S Hannon; Silva A Arslanian; Dana L Rofey Journal: J Obes Date: 2012-08-26
Authors: Amy S Thomas; Lori F Greene; Jamy D Ard; Robert A Oster; Betty E Darnell; Barbara A Gower Journal: Diabetes Care Date: 2008-10-07 Impact factor: 17.152
Authors: Andy R Ness; Sam D Leary; Calum Mattocks; Steven N Blair; John J Reilly; Jonathan Wells; Sue Ingle; Kate Tilling; George Davey Smith; Chris Riddoch Journal: PLoS Med Date: 2007-03 Impact factor: 11.069